Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. (Record no. 21395083)

MARC details
000 -LEADER
fixed length control field 02435 a2200673 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516070901.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201203s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1474-5488
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/S1470-2045(11)70300-X
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Trappe, Ralf
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120320
245 00 - TITLE STATEMENT
Title Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. The Lancet. Oncology
Date of publication, distribution, etc. Feb 2012
300 ## - PHYSICAL DESCRIPTION
Extent 196-206 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Murine-Derived
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antigens, CD20
General subdivision immunology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Doxorubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epstein-Barr Virus Infections
General subdivision diagnosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element France
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Germany
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Herpesvirus 4, Human
General subdivision pathogenicity
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoproliferative Disorders
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Organ Transplantation
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prednisolone
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rituximab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vincristine
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Oertel, Stephan
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leblond, Veronique
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mollee, Peter
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sender, Monica
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reinke, Petra
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Neuhaus, Ruth
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lehmkuhl, Hans
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Horst, Heinz August
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Salles, Gilles
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Morschhauser, Franck
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jaccard, Arnaud
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lamy, Thierry
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leithäuser, Malte
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zimmermann, Heiner
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anagnostopoulos, Ioannis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raphael, Martine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Riess, Hanno
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Choquet, Sylvain
773 0# - HOST ITEM ENTRY
Title The Lancet. Oncology
Related parts vol. 13
-- no. 2
-- p. 196-206
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/S1470-2045(11)70300-X">https://doi.org/10.1016/S1470-2045(11)70300-X</a>
Public note Available from publisher's website

No items available.